ECHELON-2 Ushers In Another New Adcetris Indication For Seattle Genetics

The combination of Adcetris with chemotherapy improved progression-free and overall survival in peripheral T-cell lymphoma. Filing is expected soon, and approval will help the product reach blockbuster status.